08:42am Sunday 24 September 2017

New Device Enables 3D Tissue Engineering with Multicellular Building Blocks

Andrew Blakely, MD, Kali Manning, Anubhav Tripathi, PhD, and Jeffrey Morgan, PhD, Rhode Island Hospital and Brown University, Providence, RI, developed the manual Bio-P3 device, and in the article “Bio-Pick, Place, and Perfuse: A New Instrument for 3D Tissue Engineering,” they explain how the device is able to grip, transport, and release multi-cellular microtissues grown in the laboratory, with minimal effects on the viability of the cells or the structure of the microtissue construct. The authors describe the design of the device’s gripper and build heads and the peristaltic pump-driven fluid dynamics used to create and maintain contact between the device heads and the microtissues. They discuss applications of the device, the potential for automation, challenges, and future directions.

“This device can be the long-expected breakthrough in the field of regenerative medicine and hopefully allow the fabrication of large 3D organs and tissues,” says John A. Jansen, DDS, PhD, Co-Editor-in-Chief Tissue Engineering, Part C: Methods and Professor and Head of Dentistry, Radboud University Medical Center, The Netherlands.

About the Journal
Tissue Engineering is an authoritative peer-reviewed journal published monthly online and in print in three parts: Part A, the flagship journal published 24 times per year; Part B: Reviews, published bimonthly, and Part C: Methods, published 12 times per year. Led by Co-Editors-In-Chief Antonios Mikos, PhD, Louis Calder Professor at Rice University, Houston, TX, and Peter C. Johnson, MD, Vice President, Research and Development and Medical Affairs, Vancive Medical Technologies, an Avery Dennison business,  and President and CEO, Scintellix, LLC, Raleigh, NC, the Journal brings together scientific and medical experts in the fields of biomedical engineering, material science, molecular and cellular biology, and genetic engineering. Tissue Engineering is the official journal of the Tissue Engineering & Regenerative Medicine International Society (TERMIS). Complete tables of content and a sample issue may be viewed online at the Tissue Engineering website.  

About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Stem Cells and Development, Human Gene Therapy, and Advances in Wound Care. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.


Share on:
or:

MORE FROM Medical Breakthroughs

Health news